iwMyeloma 2023 | Latest advances in T-cell engaging therapies for multiple myeloma
Adam Cohen, Maria-Victoria Mateos, Nizar Bahlis and Yi Lin
• 15 Apr 2023
In this discussion filmed at the 16th International Workshop on Multiple Myeloma (iwMyeloma) held in Madrid, Spain, María-Victoria Mateos, MD, PhD, University of Salamanca, Salamanca, Spain, Yi Lin, MD, PhD, Mayo Clinic, Rochester, MN, Adam Cohen, MD, University of Pennsylvania, Philadelphia, PA, and Nizar Bahlis, MD, University of Calgary, Calgary, Canada, share the latest updates on T-cell engaging therapies for multiple myeloma, commenting on ciltacabtagene autoleucel (cilta-cel), idecabtagene vicleucel (ide-cel), teclistamab, elranatamab and talquetamab.
